Doaa Ashraf Abd El-Ghany
Cairo, Egypt
Location contact
Azza Barmoud Nashed Kassab, PhD
PRINCIPAL_INVESTIGATOR
Doaa Ashraf Abd El-Ghany, B.Sc
CONTACT
Manal Ahmed El-Shafei, PhD
CONTACT
Mohamed Fawzy Aboeleinen, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06578013
This study will be conducted to determine the effect of acupressure ice massage on primary dysmenorrhea.
Trial opening soon.
Get Notified17 year–25 year
Female
Interventional
Not applicable
Cairo, Egypt
Azza Barmoud Nashed Kassab, PhD
PRINCIPAL_INVESTIGATOR
Doaa Ashraf Abd El-Ghany, B.Sc
CONTACT
Manal Ahmed El-Shafei, PhD
CONTACT
Mohamed Fawzy Aboeleinen, PhD
PRINCIPAL_INVESTIGATOR
Dysmenorrhea is considered the most common gynecological complaint by young women and affects approximately 60-80% of the female population. Around 8-18% of that population report intense discomfort, causing absenteeism in several daily activities while suffering pain.
Analgesics are considered the first line of treatment, but they are known for their undesirable effects such as renal, cardiovascular and gastrointestinal complications that can negatively affect patients' health. Physical therapy has alternative techniques that assist in analgesia in a practical and effective way; among them is acupressure and cryo therapy.
The effect of application of ice on the skin has a direct action on neurons and pain receptors, lowering the speed and the number of nerve impulses. This effect is due to its action on the gate control of pain mechanism, leading to the release of endorphins and enkephalins that are pain-relieving substances.
It was proved from previous studies that using ice massage on L14 or SP6 points reduce pain intensity in females suffering from PD. So, further studies are needed to investigate the effect of acupressure ice massage not only on pain intensity but also on other symptoms severity and quality of life of females suffering from PD. Therefore, this study will be conducted for this issue which will be of valuable benefits for medical service organization and increase body of knowledge of physical therapy in scientific field.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
It will be assessed for each participant in both groups (A & B) before and after treatment, using the visual analogue scale (VAS). The VAS is usually presented as a 10 cm horizontal line on which the participants' pain intensity is represented by a point between the extremes of " no pain at all " and " worst pain imaginable ". It's simplicity, reliability and validity as well as its ratio scale properties make the VAS the optional tool for describing pain intensity.
Time frame: 3 months
A pressure algometer will be used to measure pain pressure thresholds (PPTs) for all participants in both groups before and after treatment, coinciding with peak menstrual pain on the first day of menstruation. Six specific points around the umbilicus and lower back will be assessed, with each point measured twice using a 1-cm² probe applied at 30kPa/s. The areas will be cleaned with alcohol before testing. Two points will be measured 4cm bilaterally from the umbilicus, two more 4cm below these, one 4cm below the umbilicus, and one in the lumbar region at S2-S4. The mean values of these points will be used for PPT data analysis.
Time frame: 3 months
It will be used pre and post- treatment to assess the severity of symptoms of primary dysmenorrhea for all participants in both groups (A & B). The MDQ consists of symptoms or feelings associated with menstruation. The total number of items is 47. It is a 5 point rating scale from 0-4. For each items, there is 5 options i.e. No, mild, moderate, severe and very severe. An option of (very severe) has a score of 4, (severe) has a score of 3, (moderate) has a score of 2, (mild) has a score of 1, (No) has a score of 0. It includes seven sub-scales as (pain, water retention, autonomic reactions, negative affect, impaired concentration, mood and behavioral changes, arousal control). Overall Score was interpreted as follows :< 50 - mild , 50 to 70 - moderate and >70 severe.
Contact information is provided by the study sponsor or research team.
Doaa Ashraf Abd El-Ghany, B.Sc
CONTACT
Manal Ahmed El-Shafei, PhD
CONTACT
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07658859
Primary Dysmenorrhea
View Trial DetailsNCT07176780
Dysmenorrhea, Menstrual Cramps
View Trial DetailsNCT07529561
Menstural Cramps, Primary Dysmenorrhea
Nellore, Andhra Pradesh, India
View Trial DetailsNCT07376759
Menstruation Disturbances, Pathologic Processes
View Trial Details